logo-loader
viewAIBIOS

AIBIOS using quantum computing platform to investigate anti-inflammatory diseases

AIBIOS Inc CEO Akio Sato sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Japan-based company is investigating the anti-inflammatory benefits of synthesized compounds using a quantum computing platform.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Genprex sees newly licensed diabetes gene therapy as an...

Genprex Inc (NASDAQ:GNPX) CEO Rodney Varner tells Proactive the Texas-based biotech has signed a licensing agreement with the University of Pittsburgh for a diabetes gene therapy that could have the potential to treat Type 1 and Type 2 diabetes. Varner says the newly licensed diabetes gene...

2 days, 15 hours ago

2 min read